everolimus
Everolimus is a drug used to treat Breast Cancer, Neuroendocrine Tumors, Renal Cell Carcinoma, and other conditions. Everolimus is being actively studied in 84 studies and prior, has been studied in 240.
Top Sponsors | Top Sites | Top Investigators |
---|---|---|
Novartis Pharmaceuticals | Novartis Investigative Site | Helio Tedesco Silva Junior |
M.D. Anderson Cancer Center | Memorial Sloan Kettering Cancer Center | Ingrid Mayer, MD |
National Cancer Institute (NCI) | Dana-Farber Cancer Institute | Taofeek K. Owonikoko |
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
G
Not yet recruiting
- Estrogen Receptor (ER)-Positive, HER2-negative, Locally Advanced or Metastatic Breast Cancer
- Giredestrant
- +4 more
- (no location specified)
2022-03-23
Mar 23, 2022M
Completed
- Bladder Cancer
- Metastatic Transitional Cell Carcinoma
- Everolimus
- New York, New YorkMemorial Sloan Kettering Cancer Center
2021-12-16
Dec 16, 2021N
Completed
- Brain Tumor
- +2 more
- everolimus
- sorafenib
- Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
2022-01-07
Jan 7, 2022Y
Terminated
- Breast Cancer
- Everolimus
- New Haven, ConnecticutYale University
2022-01-12
Jan 12, 2022Y
Recruiting
- Renal Cell Carcinoma
- Lenvatinib
- +2 more
- Iowa City, IowaUniversity of Iowa Hospitals and Clinics
2021-12-13
Dec 13, 2021U
Terminated
- Low Grade Glioma
- +3 more
- Everolimus
- Temozolomide
- San Francisco, CaliforniaUniversity of California, San Francisco
2021-11-03
Nov 3, 2021F
Not yet recruiting
- Renal Cell Carcinoma
- Anlotinib hydrochloride
- everolimus
- Shanghai, China270 Dongan Road, Fudan University Shanghai Cancer Center
2021-11-05
Nov 5, 2021T
Active, not recruiting
- Differentiated Thyroid Cancer
- Everolimus
- Sorafenib
- Philadelphia, PennsylvaniaHospital of the University of Pennsylvania
2021-10-18
Oct 18, 2021U
Recruiting
- Classical Hodgkin Lymphoma
- Itacitinib
- Everolimus
- Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
2021-07-23
Jul 23, 2021E
Completed
- Solid Organ Malignancies
- +2 more
- Lenalidomide
- Everolimus
- Atlanta, Georgia
- +1 more
2021-11-19
Nov 19, 2021S
Completed
- Breast Cancer
- Everolimus
- +4 more
- Guangzhou, Guangdong, ChinaSun-Yat-Sen Memorial Hospital of Sun-Yat-Sen University
2021-09-22
Sep 22, 2021N
Completed
- Epilepsy
- +2 more
- Everolimus
- New York, New YorkNew York University Langone Medical Center
2021-08-31
Aug 31, 2021A
Active, not recruiting
- Breast Cancer
- Ovarian Cancer
- niraparib
- everolimus
- Sioux Falls, South DakotaAvera Cancer Institute
2021-08-24
Aug 24, 2021U
Terminated
- Glioma
- +2 more
- Dasatinib
- Everolimus
- Ann Arbor, MichiganUniversity of Michigan Cancer Center
2021-10-12
Oct 12, 2021U
Terminated
- Breast Neoplasms
- +2 more
- letrozole
- +2 more
- Baltimore, MarylandUniversity of Maryland Marlene & Stewart Greenebaum Cancer Cente
2022-02-09
Feb 9, 2022H
Completed
- Kidney Transplant Infection
- Sirolimus
- +2 more
- São Paulo, Sao Paulo, BrazilHospital do Rim
2021-08-23
Aug 23, 2021S
Active, not recruiting
- Glioblastoma Multiforme
- Glioma of Brain
- Ribociclib
- Everolimus
- Chandler, Arizona
- +2 more
2022-03-10
Mar 10, 2022T
Suspended
- Thyroid Cancer
- Lenvatinib
- Everolimus
- Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
2021-10-07
Oct 7, 2021M
Completed
- Prostate Cancer
- apalutamide
- Everolimus
- New York, New YorkMemorial Sloan Kettering Cancer Center
2021-06-29
Jun 29, 2021U
Active, not recruiting
- Recurrent Childhood Ependymoma
- Everolimus
- Stanford, California
- +3 more
2022-01-31
Jan 31, 2022M
Active, not recruiting
- Advanced Cancers
- Solid Tumors
- Pazopanib
- Everolimus
- Houston, TexasUniversity of Texas MD Anderson Cancer Center
2021-06-15
Jun 15, 2021H
Withdrawn
- Facial Angiofibromas
- Everolimus
- Placebo
- Bron, FranceHopital Femme Mère Enfant
2021-04-28
Apr 28, 2021N
Not yet recruiting
- Renal Angiomyolipoma
- Everolimus
- (no location specified)
2022-02-16
Feb 16, 2022M
Recruiting
- Advanced Carcinoid Tumor
- +4 more
- Everolimus
- Lenvatinib
- Houston, TexasM D Anderson Cancer Center
2021-10-19
Oct 19, 2021W
Terminated
- Adenocarcinoma
- Pancreatic Neoplasms
- X-82
- Everolimus
- Saint Louis, Missouri
- +1 more
2021-06-15
Jun 15, 2021